1. A Novel Double-Enhanced Suicide Gene Therapy in a Colon Cancer Cell Line Mediated by Gef and Apoptin
   Houria Boulaiz et al, 2014, BioDrugs CrossRef
2. Killing of cancer cells through the use of eukaryotic expression vectors harbouring genes encoding nucleases and ribonuclease inhibitor
   Elena M. Glinka, 2015, Tumor Biology CrossRef
3. Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
   ZHEN-HAI ZHANG et al, 2014, Oncology Letters CrossRef
4. Enhancement of expression of survivin promoter-driven CD/TK double suicide genes by the nuclear matrix attachment region in transgenic gastric cancer cells
   Ying Niu et al, 2014, Gene CrossRef
5. Dual-modality imaging demonstrates the enhanced antitumoral effect of herpes simplex virus-thymidine kinase/ganciclovir plus gemcitabine combination therapy on cholangiocarcinoma
   JIANFENG WANG et al, 2016, Experimental and Therapeutic Medicine CrossRef
6. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma
   Zhong-xue Su et al, 2014, Diagnostic Pathology CrossRef
7. Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma
   Chang Liu et al, 2019, Experimental Cell Research CrossRef
8. Suicide gene therapy-mediated purine nucleoside phosphorylase/fludarabine system for in vitro breast cancer model with emphasis on evaluation of vascular endothelial growth factor promoter efficacy
   Akbar Abbaspour et al, 2021, 3 Biotech CrossRef
9. Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma
   Bijay Dhungel et al, 2017, Drug Delivery CrossRef
10. Emerging Therapies for Hepatocellular Carcinoma (HCC)
    Eesha Chakraborty et al, 2022, Cancers CrossRef
11. Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives
    Ning-ning Yue et al, 2023, Molecular Therapy - Oncolytics CrossRef
12. HSVtk/GCV system on hepatoma carcinoma cells: Construction of the plasmid pcDNA3.1-pAFP-TK and targeted killing effect
    Yong-Fang Li et al, 2017, Molecular Medicine Reports CrossRef
13. Exploiting the unique regenerative capacity of the liver to underpin cell and gene therapy strategies for genetic and acquired liver disease
    Grant J. Logan et al, 2014, The International Journal of Biochemistry & Cell Biology CrossRef
14. Exogenous p53 and ASPP2 expression enhances rAdV-TK/GCV-induced death in hepatocellular carcinoma cells lacking functional p53
    Xiuhong Liu et al, 2016, Oncotarget CrossRef
15. Combined antitumor activity of the nitroreductase/CB1954 suicide gene system and γ-rays in HeLa cells in vitro
    Geling Teng et al, 2016, Molecular Medicine Reports CrossRef
16. A Unique Core–Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects
    Bei Cheng et al, 2022, Pharmaceutics CrossRef
17. A double suicide gene system driven by vascular endothelial growth factor promoter selectively kills human hepatocellular carcinoma cells
    KAI WU et al, 2016, Oncology Letters CrossRef
18. β2-Adrenergic receptor agonist enhances the bystander effect of HSV-TK/GCV gene therapy in glioblastoma multiforme via upregulation of connexin 43 expression
    Saereh Hosseindoost et al, 2022, Molecular Therapy - Oncolytics CrossRef
19. Construction of plasmid vector pAFP-HSVtk-IRES2-EGFP and its effect on the cytotoxicity of ganciclovir to hepatocellular carcinoma
    Zhiyong Lai et al, 2014, Chinese Medical Journal CrossRef
20. Connexin32-mediated antitumor effects of suicide gene therapy against hepatocellular carcinoma: In vitro and in vivo anticancer activity
    LUN WU et al, 2016, Molecular Medicine Reports CrossRef